ZONAGEN INC
10-Q, EX-11.1, 2000-08-11
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Previous: ZONAGEN INC, 10-Q, 2000-08-11
Next: ZONAGEN INC, 10-Q, EX-27.1, 2000-08-11



<PAGE>   1
                                                                    EXHIBIT 11.1



              STATEMENT REGARDING COMPUTATION OF NET LOSS PER SHARE

<TABLE>
<CAPTION>
THREE MONTHS ENDED JUNE 30, 2000
--------------------------------
                    Net Loss        Weighted Average Shares Outstanding          Loss per Share
                    --------        -----------------------------------          --------------
<S>               <C>                                <C>                             <C>
Basic             $1,282,000        divided by       11,307,000            =          $0.11
Diluted           $1,282,000        divided by       11,307,000            =          $0.11
</TABLE>

<TABLE>
<CAPTION>
SIX MONTHS ENDED JUNE 30, 2000

                    Net Loss        Weighted Average Shares Outstanding          Loss per Share
                    --------        -----------------------------------          --------------
<S>               <C>                                <C>                             <C>
Basic             $2,940,000        divided by       11,289,000            =          $0.26
Diluted           $2,940,000        divided by       11,289,000            =          $0.26
</TABLE>



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission